Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 531

1.

Health effects of a forest environment on natural killer cells in humans: an observational pilot study.

Tsao TM, Tsai MJ, Hwang JS, Cheng WF, Wu CF, Chou CK, Su TC.

Oncotarget. 2018 Mar 27;9(23):16501-16511. doi: 10.18632/oncotarget.24741. eCollection 2018 Mar 27.

2.

Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver.

Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, Li H, Qi J, Ding L, Li T, Zhang R, Chen Y, Zhou J, Lv G, Tu Z.

Oncotarget. 2018 Feb 15;9(21):15552-15565. doi: 10.18632/oncotarget.24514. eCollection 2018 Mar 20.

3.

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.

Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S, Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L, Parati EA, Bruzzone MG, Finocchiaro G.

Oncoimmunology. 2018 Jan 29;7(4):e1412901. doi: 10.1080/2162402X.2017.1412901. eCollection 2018.

4.

Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment.

Golden-Mason L, McMahan RH, Kriss MS, Kilgore AL, Cheng L, Dran RJ, Wieland A, Rosen HR.

Hepatol Commun. 2018 Mar 1;2(4):364-375. doi: 10.1002/hep4.1166. eCollection 2018 Apr.

5.

Regulation of Human Natural Killer Cell IFN-γ Production by MicroRNA-146a via Targeting the NF-κB Signaling Pathway.

Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N, Peng Y, Yu J.

Front Immunol. 2018 Mar 9;9:293. doi: 10.3389/fimmu.2018.00293. eCollection 2018.

6.

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.

Eaton N, Cabanas H, Balinas C, Klein A, Staines D, Marshall-Gradisnik S.

BMC Pharmacol Toxicol. 2018 Mar 27;19(1):12. doi: 10.1186/s40360-018-0203-8.

7.

Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination.

Costanzo MC, Kim D, Creegan M, Lal KG, Ake JA, Currier JR, Streeck H, Robb ML, Michael NL, Bolton DL, Steers NJ, Eller MA.

Nat Commun. 2018 Mar 23;9(1):1212. doi: 10.1038/s41467-018-03618-w.

8.

Impaired natural killer cell subset phenotypes in human obesity.

Bähr I, Jahn J, Zipprich A, Pahlow I, Spielmann J, Kielstein H.

Immunol Res. 2018 Apr;66(2):234-244. doi: 10.1007/s12026-018-8989-4.

9.

Ex vivo expansion of human peripheral blood natural killer cells and cytotoxic T lymphocytes from lung cancer patients.

Nhung HTM, Anh BV, Huyen TL, Hiep DT, Thao CT, Lam PN, Liem NT.

Oncol Lett. 2018 Apr;15(4):5730-5738. doi: 10.3892/ol.2018.8029. Epub 2018 Feb 12.

10.

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

Mehta RS, Rezvani K.

Front Immunol. 2018 Feb 15;9:283. doi: 10.3389/fimmu.2018.00283. eCollection 2018. Review.

11.

Immunotherapy for Dogs: Running Behind Humans.

Klingemann H.

Front Immunol. 2018 Feb 5;9:133. doi: 10.3389/fimmu.2018.00133. eCollection 2018. Review.

12.

Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.

Hanazawa A, Ito R, Katano I, Kawai K, Goto M, Suemizu H, Kawakami Y, Ito M, Takahashi T.

Front Immunol. 2018 Feb 2;9:152. doi: 10.3389/fimmu.2018.00152. eCollection 2018.

13.

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.

Lieberman NAP, DeGolier K, Haberthur K, Chinn H, Moyes KW, Bouchlaka MN, Walker KL, Capitini CM, Crane CA.

Front Immunol. 2018 Feb 2;9:150. doi: 10.3389/fimmu.2018.00150. eCollection 2018.

14.

IL-10+ NK and TGF-β+ NK cells play negative regulatory roles in HIV infection.

Jiang Y, Yang M, Sun X, Chen X, Ma M, Yin X, Qian S, Zhang Z, Fu Y, Liu J, Han X, Xu J, Shang H.

BMC Infect Dis. 2018 Feb 13;18(1):80. doi: 10.1186/s12879-018-2991-2.

15.

Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation.

Ziblat A, Nuñez SY, Raffo Iraolagoitia XL, Spallanzani RG, Torres NI, Sierra JM, Secchiari F, Domaica CI, Fuertes MB, Zwirner NW.

Front Immunol. 2018 Jan 17;8:1959. doi: 10.3389/fimmu.2017.01959. eCollection 2017.

16.

Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain.

Yoon JJ, Song JA, Park SY, Choi JI.

Korean J Pain. 2018 Jan;31(1):43-49. doi: 10.3344/kjp.2018.31.1.43. Epub 2018 Jan 2.

17.

NK Cells and Their Role in Invasive Mold Infection.

Schmidt S, Condorelli A, Koltze A, Lehrnbecher T.

J Fungi (Basel). 2017 May 19;3(2). pii: E25. doi: 10.3390/jof3020025. Review.

18.

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.

Uppendahl LD, Dahl CM, Miller JS, Felices M, Geller MA.

Front Immunol. 2018 Jan 5;8:1825. doi: 10.3389/fimmu.2017.01825. eCollection 2017. Review.

19.

A functional DC cross talk promotes human ILC homeostasis in humanized mice.

Lopez-Lastra S, Masse-Ranson G, Fiquet O, Darche S, Serafini N, Li Y, Dusséaux M, Strick-Marchand H, Di Santo JP.

Blood Adv. 2017 Apr 6;1(10):601-614. doi: 10.1182/bloodadvances.2017004358. eCollection 2017 Apr 11.

20.

Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.

Zhong H, Hu X, Janowski AB, Storch GA, Su L, Cao L, Yu J, Xu J.

Sci Rep. 2017 Dec 19;7(1):17775. doi: 10.1038/s41598-017-18195-z.

Supplemental Content

Support Center